Flow cytometric visualisation of cytokine production by CD3-CD56+ NK cells and CD3+CD56+ NK-T cells in whole blood

Cytometry

Volumn 39, Issue 1, 2000, Pages 72-78

  Mendes, R ^a,b   Bromelow, K V ^a   Westby, M ^c   Galea Lauri, J ^a   Smith, I E ^b   O'Brien, M E R ^b,d   Souberbielle, Bernard E ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ROCHE PRODUCTS LTD   (United Kingdom)

^d MAIDSTONE HOSPITAL   (United Kingdom)

Author keywords

Flow cytometry; Interferon ; Intracellular cytokine analysis; Natural killer cells; Tumour necrosis factor

Indexed keywords

BREFELDIN A; CD3 ANTIGEN; CD56 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IONOMYCIN; PHORBOL 12 ACETATE 13 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL STIMULATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033987694     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(20000101)39:1<72::AID-CYTO10>3.0.CO;2-R     Document Type: Article

References (39)

1. Biron CA. Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 1997;19:24-34.
2. Bruunsgaard H, Pedersen C, Skinhoj P, Perdersen BK. Clinical progression of HIV infection: role of NK cells. Scand J Immunol 1997; 46:91-95.
3. Whiteside TL, Heberman RB. The role of natural killer cells in immuno-surveillance of cancer. Curr Opin Immunol 1995;7:704-710.
4. Ljungrren H-G, Karre K. Host resistance directed selectively against H-2 deficient lymphoma variants: analysis of mechanisms. J Exp Med 1985;162:1745-1759.
5. Prussin C, Metcalfe DD. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 1995;188:117-128.
6. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B, Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med 1998;188:2375-2380.
7. Peritt D, Roberston S, Gri G, Showe L, Aste-Amezag M, Trinchieri G. Cutting edge: differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 1998;161:5821-5824.
8. Anegon I, Cuturi G, Trinchieri G, Perussia B. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J Exp Med 1988;167:452-472.
9. Cuturi MC, Anegon F, Sherman R, Loudon R, Clark C, Perussia B, Trinchieri G. Production of hematopoietic colony-stimulating factors by natural killer cells. J Exp Med 1989;169:569-583.
10. Mehrotra PT, Donnely RP, Wong S, Kanegane H, Geremew A, Mostowski HS, Furuke K, Siegel JP, Bloom ET. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J Immunol 1998;160:2637-2644.
11. Warren HS, Kinnear FB, Phillips JH, Lanier LL. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10 and IL-12. J Immunol 1996;154:5144-5152.
12. Bromelow KV, Galea-Lauri J, O'Brien ME, Souberbielle BE. A highly sensitive whole blood natural killer cell assay. J Immunol Methods 1998;217:177-184.
13. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993; 159:197-207.
14. Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR, Maino VC. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995;86:1408-1419.
15. Jason J, Larned J. Single-cell cytokine profiles in normal humans: comparison of flow cytometric reagents and stimulation protocols. J Immunol Methods 1997;207:13-22.
16. Suni MA, Picker LJ, Maino VC. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods 1998;212:89-98.
17. Waldrop SL, Pitcher CJ, Peterson DM, Maino VC, Picker LJ. Determination of antigen-specific: memory/effector CD4+ T cell frequency by flow cytomctry - evidence for a novel antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 1997;99:1739-1750.
18. Murali-Krishna K, Altman JD, Suresh M, Sourdive D, Zajac A, Miller J, Slansky J, Ahmed R. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998;8:177-187.
19. Perussia B, Trinchieri G, Jackson A, Warner NL, Faust J, Rumpold H, Kraft D, Lanier LL. The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol 1984;133:180-189.
20. Henney CS, Kuribayashi K., Kern DE, Gillis S. Interleukin-2 augments natural killer cell activity. Nature 1981;291:335-338.
21. Gumperz JE, Parham P. The enigma of the natural killer cell. Nature 1995;378:245-248.
22. Lanier LL. NK cell receptors. Annu Rev Immunol 1998;16:359-393.
23. Ross ME, Caligiuri MA. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 1997;89:910-918.
24. Jewett A, Calvalcanti M, Bonavida B. Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells. J Immunol 1997;159:4815-4822.
25. Aguet M, Dembic Z, Merlin G. Molecular cloning and expression of the human interferon-gamma receptor. Cell 1988;55:273-280.
26. Klausner RD, Donaldson, JG, Lippincott-Schwartz J, Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 1992;116:1071-1080.
27. Elia JM, Chu EB, Ernst DN, Shih CC. Differential effect of monensin versus brefeldin A on intracellular cytokine staining. J Allergy Clin Immunol 1997;99(Pt 2, SS):1284.
28. Openshaw P, Murphy EE, Hosken NA, Maino V, Davis K, Murphy K, O'Garra A. Heterogeneity of intracellular cytokine synthesis at the single level in polarized T-helper-1 and T-helper-2 populations. J Exp Med 1995;182:1357-1367.
29. Schmidt-Wolf IG, Negrin RS, Kiem H, Blume KG, Weissman IL. Use of SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumour cell activity. J Exp Med 1991;174: 139-149.
30. Lu PH, Negrin RS. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumour activity in mice with severe combined immunodeficiency. J Immunol 1994;153:1687-1695.
31. Frassanito MA, Silvestris F, Cafforio P, Dammacco F. CD8+/CD57+ cells and apoptosis suppress T-cell functions in multiple myeloma. Br J Haematol 1998;100:469-477.
32. Gorochov G, Debre P, Leblond V, Sadat-Sowti B, Sigaux X, Autran B. Oligoclonal expansion of CD8+CD57+ T cells with restricted T cell receptor β-chain variability after bone marrow transplantation. Blood 1994;83:587-595.
33. Sata-Sowti B, Debre P, Mollet L, Quint L, Hadida F, Leblond V, Bismuth G, Autran B. An inhibitor of cytotoxic functions produced by CD8+CD57+ T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients. Eur J Immunol 1994; 24:2882-2888.
34. Rizzardi GP, Brown L, Souberbielle BE, Dalgleish AG. An alternative to Cr-51 release assay for measurement of natural killer activity in HIV-infected patients. AIDS 1996;10:676-677.
35. Whiteside TL, Heberman RB. The role of natural killer cells in human disease. Clin Immunol Immunopathol 1989;53:1-23.
36. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998;391:397-401.
37. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard J. Endocytosis of major histocompatibility complex class 1 molecules is induced by the Nef protein. Nat Med 1996;2:338-342.
38. Westby M, Marriott JB, Guckian M, Cookson S, Hay P, Dalgleish AG. Abnormal intracellular IL-2 and interferon-gamma (IFN-gamma) production as HIV-1-associated markers of immune dysfunction. Clin Exp Immunol 1998;111:257-263.
39. Pierson BA, Miller JS. CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis. Blood 1996;88:2279-2287.